Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mathai Mammen currently holds 180,259 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mathai Mammen has been a net seller of TBPH stock. They have purchased $0 and sold $4.7M worth of shares.
Mathai Mammen's most recent insider trade was on Jun 11, 2024, when they sold 8,649 shares at $0.00 per share.
Mathai Mammen serves as Executive at Theravance Biopharma, Inc. (TBPH). They have executed 82 insider transactions totaling $4.7M over their tenure at the company.
Mathai Mammen holds the position of Executive at Theravance Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Mathai Mammen has shown a selling trading pattern, with $0 in total purchases and $4.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mathai Mammen was on May 11, 2023, when they sold $1.7M worth of TXG shares. This transaction involved 33,000 shares at $52.82 per share.
Mathai Mammen currently owns 180,259 shares of Theravance Biopharma, Inc. (TBPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mathai Mammen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mathai Mammen has 82 Form 4 filings on record as an insider at Theravance Biopharma, Inc..
Set alerts for Mathai Mammen and 40,000+ other insiders.